Urinary Tract Infection Bacterial Clinical Trial
Official title:
Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae: a Multicenter Case-control Study.
To assess the efficacy of temocillin compared to carbapenems for the management of ESBL-E UTI.
Adults with a definite diagnosis of ESBL-E UTI between January-2015 and October-2019 were enrolled in a multicenter retrospective case-control study. Cases were treated with temocillin ≥50% of the effective antibiotic therapy duration. Control exclusively received carbapenem over the effective antibiotic therapy duration. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02543827 -
Evaluation of the Efficacy and Safety of MV140
|
Phase 3 | |
| Recruiting |
NCT04291768 -
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
|
Phase 4 | |
| Recruiting |
NCT05667207 -
Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)
|
N/A | |
| Completed |
NCT03774940 -
Blood Parameters as a Predictor of Fever After Percutaneous Nephrolithotomy
|
N/A | |
| Terminated |
NCT04287478 -
Bacteriophage Therapy in Patients With Urinary Tract Infections
|
Phase 1/Phase 2 | |
| Completed |
NCT03801213 -
Evaluation of Urine Samples Obtained by Bladder Stimulation for the Diagnosis of Urinary Tract Infection in Infants
|
N/A | |
| No longer available |
NCT04173013 -
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
|